Shares of Encompass Health Corp (NYSE:EHC) have been assigned an average recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $80.75.
Separately, ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.
Shares of Encompass Health stock traded down $0.12 on Friday, reaching $59.25. The stock had a trading volume of 1,380,903 shares, compared to its average volume of 861,821. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 1.71. Encompass Health has a 1 year low of $56.74 and a 1 year high of $82.46. The company has a market cap of $6.01 billion, a P/E ratio of 16.32, a PEG ratio of 2.04 and a beta of 0.74.
The business also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s dividend payout ratio is presently 29.75%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Recommended Story: Relative Strength Index
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.